pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3618 |
Genomic Coordinates | chr22: 20085746 - 20085833 |
Description | Homo sapiens miR-3618 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3618 | ||||||||||||||
Sequence | 52| UGUCUACAUUAAUGAAAAGAGC |73 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
DRVs in miRNA |
|
||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | BBS5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Description | Bardet-Biedl syndrome 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transcript | NM_152384 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Expression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Putative miRNA Targets on BBS5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3'UTR of BBS5 (miRNA target sites are highlighted) |
>BBS5|NM_152384|3'UTR 1 TTGACCTTGAGTTGAGATGGATTTCTATTAAAGATATCTCTAGTTTAAAGATACTAGTCACCTGCCATAAGTCATGGAAT 81 AGTTTTTATATTTACAGCTTTTATATTTAAAACTTGTAAGAGTTTTTTTAATGATTGAGGAAAAAGTCATTTAGAAAACT 161 TCAGTTTTCGGCCAGCGCGTCGAGGGAGGGGCCAGCGACACATGGCCTAGTAACCGTCCGGCCGCGGCGCTGGCTTAAGC 241 CATGGCTGAGGGTAGCTGGATTCCTCAGGCCCGGGCGCTCCTACAGCAGTGCCTGCACGCCCGGCTGCAAATTCGCCCAG 321 CCAATGGGGACGTTGCGGCCCAGTGGGTGGAGGTCCAAAGAGGACTGGTGATCTACGTGTGCTTTTTCAAGGGAGCTGAT 401 AAAGAACTTCTTCCCAAAATGGCCGAAGCTGGACTGTACTGCTGCCATCTCTGGCTCACTGCAACCTCCCTGCCTGATTC 481 TCCTGCCTCAGCCTGCCGAGTGCCTGCGATTACAGGCGCGCGCCGCCACACCTGACTGGTTTTCGTATTTTTTTGGTGGA 561 GACGGGGTTTCGCTGTGTTGGCCGGGCTGGTCTCCAGCTCCTAACCGCGAGTGATCCGCCAGCCTCGGCCTCCCGAGGTG 641 CCGGGATTGCAGACGGAGTCTGGTTCACTTAGTGCTCAATGGTGCCCAGGCTGGAGTGCAGTGGCGTGATCTCCGCTCGC 721 TACAACCTCCACCTCCCAGCTGCCTGCCTTGGCCTCCCGAAGTGCCAAGAGTGCAGCCTCTGCCCGGCCGCCACCCCGTC 801 TGGGAAGTGAGGAGCGTCTCTGCCTGGCTGCCCATTGTCTGGGACGTGAGCAGCCCCTCTGCCTGGCTGCCCAGTCTGGA 881 AAGTGAGGAGCGTCTCTGCCCGGCCGCCATCCCATCTAGGAAGTGAGGAGCGCCTCTTCCCACCCGCCATCCCATCTAGG 961 AAGTGAGGAGCTTCTCTGCCTGGCCGCCCATCGTCTGAGATGTGGGGAGCACCTCTGCCCGGCCGCGACCCCATTTGGGA 1041 GGTGAGGAGCAACTCTGCCCAGCCGCCCCGTCTGAGAAGTGAGGAGACCCTCCGCCTGGCAACCGCCCCGTCTGATAAGT 1121 AAGGAGCCCCTCTGCCCAGCAGCCGCCCCGTCTGAGAAGTGAGGAGCCCCTCTGCCCAGCAGCCACCCTGTCTGGGAAGT 1201 GAGGAGCGTCTCCGCCCGGCAGCCACCCAGTCCGGGAGGGAGGTGGGGGGGTCAGTCCCCCGTCCGGCCAGCCGCCCCGT 1281 CCGGGAGGTGAGGGGCGCCTCTGCCCAGCTGCCCCTACTGGGAAGTGAGGAGCCCCTCTGCCCCGCCAGCCACCCCGTCC 1361 GGGAGGGAGGTGGGGGGGTCAGCCCCCCGCCCGGCCAGCCGCCCCGTCCGGGAGGGAGGTGGGGGATCAGCCCCCCGCCC 1441 GGCTAGCCGCCCCGTCCGGGAGGCGAGGGGCGCCTCTGCCCGGCTGCCCCTACTGGGAAGTGAGGAGCCCCTCTGCCCGG 1521 CCAGCCGCCCCGTCCAGGAGGGAGGTGGGGGGGTCAGCCCCCCGCCCGGCCAGCCGCCCGGTCCGGGAGGGAGGTGGGGG 1601 GGTCAGCCCCCCGCCCGGCCAGCCGCCCCGTCCGGGAGGTTAGGGGCGCCTCTGCCCGGCCGCCCCTACTGGGAAGTGAG 1681 GAGCCCCTCTGCCCGGCCACCACCCCGTCTGGGAGGTGTACCCAACAGCTCATTGAGAGCGGGCGATGATGACAGTGGCG 1761 GCTTTGTGGAGTGGAGGTGGGGGGAAGGTGGGGAAAAGATTGAGAAATCGGATGGTTGCCGTGTCTGTGTAGAAAGAAGT 1841 AGACATGGGAGACTTTTCATTTTGTTCTGTACTAAGAAAAATTCTTACCCTAAAACTTAAAGTATAATAAAAAAAAAAAA 1921 ACTTCAGTTTTCTAAAAATTATATTTAAAATTGTAATCAAAATGTACCTAGTTTATAAATGTTTATTTTGTACTTAATAC 2001 CTGTAAAGTCTTAGTTTTCAGACATTAAGTGACTGTATCATGTTCGGTTTAATAAAGAATTTATGCAGCACCAAAAAAAA 2081 AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DRVs in gene 3'UTRs |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in gene 3'UTRs |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 129880.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000295240.3 | 3UTR | ACAUGGGAGACUUUUCAUUUUGUUCUGUACUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
29 hsa-miR-3618 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT378435 | SOX4 | SRY-box 4 | 2 | 2 | ||||||||
MIRT459627 | GABARAP | GABA type A receptor-associated protein | 2 | 2 | ||||||||
MIRT471295 | PGAM4 | phosphoglycerate mutase family member 4 | 2 | 2 | ||||||||
MIRT471369 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT504886 | MRPL51 | mitochondrial ribosomal protein L51 | 2 | 2 | ||||||||
MIRT505938 | RBM33 | RNA binding motif protein 33 | 2 | 8 | ||||||||
MIRT525461 | TMPRSS12 | transmembrane protease, serine 12 | 2 | 2 | ||||||||
MIRT526767 | ZNF527 | zinc finger protein 527 | 2 | 2 | ||||||||
MIRT526990 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT528669 | PDE4DIP | phosphodiesterase 4D interacting protein | 2 | 6 | ||||||||
MIRT538462 | CNBP | CCHC-type zinc finger nucleic acid binding protein | 2 | 2 | ||||||||
MIRT542899 | HSBP1 | heat shock factor binding protein 1 | 2 | 2 | ||||||||
MIRT550274 | AHI1 | Abelson helper integration site 1 | 2 | 2 | ||||||||
MIRT551674 | BBS5 | Bardet-Biedl syndrome 5 | 2 | 2 | ||||||||
MIRT551689 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT551755 | TRIM42 | tripartite motif containing 42 | 2 | 2 | ||||||||
MIRT555769 | PCMTD1 | protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 | 2 | 2 | ||||||||
MIRT556241 | MARCH9 | membrane associated ring-CH-type finger 9 | 2 | 2 | ||||||||
MIRT556926 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | 2 | 4 | ||||||||
MIRT562638 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT571348 | RPL37 | ribosomal protein L37 | 2 | 2 | ||||||||
MIRT612818 | KLHL3 | kelch like family member 3 | 2 | 2 | ||||||||
MIRT619329 | TIPRL | TOR signaling pathway regulator | 2 | 4 | ||||||||
MIRT653927 | SERPINC1 | serpin family C member 1 | 2 | 2 | ||||||||
MIRT659150 | DDHD1 | DDHD domain containing 1 | 2 | 2 | ||||||||
MIRT688334 | FAM126B | family with sequence similarity 126 member B | 2 | 2 | ||||||||
MIRT694760 | FZD2 | frizzled class receptor 2 | 2 | 2 | ||||||||
MIRT700477 | PUM1 | pumilio RNA binding family member 1 | 2 | 2 | ||||||||
MIRT702375 | KLF10 | Kruppel like factor 10 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|